The King is Dead, Long Live the King: Entering A New Era of Stem Cell Research and Clinical Development

In mid November the biopharma industry was shocked by the announcement from Geron that they were ending work on embryonic stem cell research and therapy. For more than 10 years the public image of all stem cell research has been equated with embryonic stem cells. Unfortunately, a fundamentally impor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichim, Thomas, Riordan, Neil H, Stroncek, David F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275507/
https://www.ncbi.nlm.nih.gov/pubmed/22185188
http://dx.doi.org/10.1186/1479-5876-9-218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275507/
https://www.ncbi.nlm.nih.gov/pubmed/22185188
http://dx.doi.org/10.1186/1479-5876-9-218

Ejemplares similares